Inpatient hospital care for psoriasis: A vanishing practice in the United States

Journal of the American Academy of Dermatology

Volumn 49, Issue 3, 2003, Pages 445-450

  Stern, Robert S ^k   Bauer, E ^a   Epstein, J H ^b   Koo, J ^b   Wolf, J ^c   Niagra, T P ^d   Anderson, T F ^e   Prystowsky, J ^f   McEvoy, M ^g   Taylor, J R ^h   Zaias, N ⁱ   Urbach, F ^j   Stern, R ^k   Baughman, R D ^l   Braverman, I M ^m   Murray, J ⁿ   Werth, V ^o   Parrish, J ^p   Sober, A ^p  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d WASHINGTON HOSPITAL CENTER   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f Columbia Univ Coll of Phys/Surgs ^*  (United States)

^g MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY OF MIAMI   (United States)

ⁱ MOUNT SINAI MEDICAL CENTER   (United States)

^j TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^l DARTMOUTH MEDICAL SCHOOL   (United States)

^m YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ DUKE UNIVERSITY MEDICAL CENTER   (United States)

^o HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^p MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; METHOXSALEN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEALTH SURVEY; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSORIASIS; PUVA; UNITED STATES;

EID: 0041355375     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0190-9622(03)00858-2     Document Type: Article

References (9)

1. Parrish JA, Fitzpatrick TB, Tanenbaum L, Pathak MA. Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med 1974;291:1207-11.
2. Stern RS, Thibodeau LA, Kleinerman RA, Parrish JA, Fitzpatrick TB, Bleich HL. Effect of methoxsalen photochemotherapy on cost of treatment for psoriasis: an example of technological assessment. JAMA 1981;245:1913-8.
3. Stern RS. Long-term use of psoralens and ultraviolet A for psoriasis: evidence for efficacy and cost savings. J Am Acad Dermatol 1986;14:520-6.
4. Stern RS, Epstein AM. Institutional responses to prospective payment based on diagnosis-related groups: implications for cost, quality, and access. N Engl J Med 1985;312:621-7.
5. Chen GJ, Feldman SR. Economic aspect of health care systems: advantage and disadvantage incentives in different systems. Dermatol Clin 2000;18:211-4.
6. Chaix-Couturier C, Durand-Zaleski I, Jolly D, Durieux P. Effects of financial incentives on medical practice: results from a systematic review of the literature and methodological issues. Int J Qual Health Care 2000;12:133-42.
7. US Department of Health and Human Services. National hospital discharge summary, multi-year data file, 1979-97. CD-Rom series 13, No 19A, July 1999. Hyattsville (MD): US Department of Health and Human Services; 1999.
8. Muller SA, Perry HO. The Goeckerman treatment in psoriasis: six decades of experience at the Mayo Clinic. Cutis 1984;34:265-70.
9. Vensel E, Hilley T, Trent J, Taylor JR, Kirsner RS, Kerdel FA, et al. Sustained improvement of the quality of life of patients with psoriasis after hospitalization. J Am Acad Dermatol 2000;43:858-60.